$36.55
-$0.50
(-1.35%)
Quote as of 4:01 PM EST on 02/10/12
Par Pharmaceutical Companies, ...
NYSE:PRX
|
$36.55
-$0.50
(-1.35%)
|
|
| Today's Open | $36.70 |
|---|---|
| Previous Close | $37.05 |
| Daily Range | $36.15 - $36.70 |
| 52-Week Range | $24.85 - $38.85 |
| Market Cap | $1.33B |
| P/E Ratio | -22.05 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 186,060 |
| Average Daily Volume | 356,974 |
| Current FY EPS | $3.29 |
PRX Information
| Description |
|---|
| The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Get These 5 Stocks While They're Hot - Investment Ideas
Lawsuit Alleges Walgreen, Par Pharma Overcharged For Generics
Pozen Inks $75 Million Royalty Deal for Treximet
Why Par Pharmaceutical May Be About to Take Off
Par Pharmaceutical Earnings Preview
FDA OKs Generics Of Zyprexa For Bipolar Disorder, Schizoprenia
Mid-Day Update: Stocks Shift Higher After Mixed Start; China, Earnings Weigh
Stocks Rebound, Trade Higher Amid Mixed Slate of Earnings; China Data Weighs
Will AstraZeneca Disappoint Analysts Next Quarter?
Generics on the Rise: A Big Threat to Big Pharma?
